If you're an avid AI user, you'll likely want to try out OpenAI's recent o1 model as it boasts some of the most advanced reasoning capabilities yet. However, if you use another model, you may not want ...

CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...

WASHINGTON, DC: Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure announced on December 5th that the manufacturers of the sickle cell disease gene therapies, Lyfgenia and ...

CMS’ upcoming ACCESS payment model is being billed as a turning point in how chronic care is reimbursed and managed — aiming to tie payments to patient outcomes and expand the use of digital tools.

The CMS CGT Access Model involves 33 states, D.C., and Puerto Rico, focusing on sickle cell disease treatments for Medicaid beneficiaries. Outcomes-based contracts with manufacturers ensure discounts ...

The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.

On Wednesday, OpenAI announced the release of two new models—o3 and o4-mini—that combine simulated reasoning capabilities with access to functions like web browsing and coding. These models mark the ...

OpenAI launched its long-awaited GPT-5 model. The model is claimed to be OpenAI's fastest, smartest, and most capable yet. GPT-5 is available to everyone: Free, Plus, Pro, and Team/Enterprise/Edu ...